Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

Clinical trial NCT00637923 · COMPLETED

Trial details

NCT number: NCT00637923
Sponsor: Romark Laboratories L.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2008-03-01
Primary completion: 2010-04-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.